News | Radiology Business | August 03, 2018

David Westgate Named Chairman, President and CEO of Carestream Health

Westgate replaces long-time CEO Kevin Hobert

David Westgate Named Chairman, President and CEO of Carestream Health

August 3, 2018 — David C. Westgate was recently named the new chairman, president and CEO of Carestream Health.

“Our focus will be on delivering innovation that is life-changing — for patients, customers, employees, communities and other stakeholders — and we will grow our business for long-term success,” said Westgate. “We are very excited about pursuing new product development road maps that will position us to meet the diverse needs of our customers in the markets we will serve. Customer satisfaction, continuous innovation and operational excellence will be fundamental to our culture and we are committed to being the very best at what we do.”

Westgate previously served as CEO of Jason Industries Inc., where he led successful efforts to diversify the company’s portfolio while emphasizing a culture of growth and innovation. Under his leadership, Jason Industries experienced increases in both revenue and earnings, and accelerated growth through acquisitions, geographic diversification, performance improvements and a focus on developing breakthrough innovations.

“Dave has an impressive record of success in corporate leadership roles and his vision for Carestream is clear: move the company toward long-term growth and market leadership, and drive continuous innovation across the company’s broad portfolio of products,” said Robert Le Blanc, a senior managing director of Onex Corp.

Westgate replaces Kevin Hobert, who had decided to leave the company and will assist with the transition. Hobert has been the CEO of Carestream since April 2007, according to Bloomberg. “Kevin Hobert has done an excellent job leading Carestream’s development into a worldwide leader in the medical and dental imaging fields, and has prepared the company for sustainable growth in the coming years. I would like to thank Kevin for the many significant contributions he has made to Carestream’s success since launching the company more than 11 years ago,” said Le Blanc.

For more information: www.carestream.com

Related Content

Advances in long-length digital radiography are creating opportunities for visualization during spinal surgery, as well as pre- and post-operatively. Image courtesy of Fujifilm Medical Systems

Advances in long-length digital radiography are creating opportunities for visualization during spinal surgery, as well as pre- and post-operatively. Image courtesy of Fujifilm Medical Systems

Feature | Digital Radiography (DR) | July 19, 2019 | By Greg Freiherr
Recent advances in...
Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Feature | Contrast Media | July 18, 2019 | By Greg Freiherr
Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n
Image by rawpixel from Pixabay

Image by rawpixel from Pixabay 

Feature | Radiology Business | July 18, 2019 | By Stefanie Manack and Judy Zakutny
Approximately 30 percent of a hospital or health system’s profit comes from imaging according, to...
CMS Proposes New Alternative Payment Model for Radiation Oncology
News | Radiation Oncology | July 17, 2019
The Centers for Medicare and Medicaid Services (CMS) issued a proposal for an advanced alternative payment model (APM)...
Mirion Showcases Instadose2 Wireless Dual Detector Dosimeter at AAPM and AHRA
News | Radiation Dose Management | July 15, 2019
Featuring dual detectors, the Instadose2 dosimeter addresses international requirements for independent deep [Hp(10)]...
FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance...
Graphic courtesy Pixabay

Graphic courtesy Pixabay

Feature | Artificial Intelligence | July 15, 2019 | By Greg Freiherr
Siemens has long focused on automation as a way to make diagnostic equipment faster and more efficient.
Routine scan of abdomen pelvis taken with the UW-Madison’s Revolution 256 CT scanner using the FDA-cleared reconstruction algorithm, called TrueFidelity.

Routine scan of abdomen pelvis taken with the UW-Madison’s Revolution 256 CT scanner using the FDA-cleared reconstruction algorithm, called TrueFidelity. UW-Madison was the first site in the U.S. to get this technology. Its use is now being integrated into UW CT protocols. Image courtesy of Timothy P. Szczykutowicz

Feature | Computed Tomography (CT) | July 12, 2019 | By Greg Freiherr
When providers develop their own imaging protocols, they are wasting time and money, according to...
SimonMed Imaging Implements ProFound AI for 3-D Tomosynthesis
News | Mammography | July 10, 2019
Arizona-based SimonMed Imaging announced their implementation of the first U.S. Food and Drug Administration (FDA)-...